Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ethanolamine kinase 2 pseudogene (ENSG00000274468) is a nonfunctional segment of DNA that shows sequence similarity to the functional ethanolamine kinase 2 gene but lacks the capability to encode a protein due to disabling mutations such as premature stop codons or frameshifts[2][1]. Pseudogenes are abundant in the human genome and generally considered genomic relics, although occasionally some pseudogenes may be transcribed and play limited regulatory roles, often by acting as non-coding RNAs or competitive endogenous RNAs in gene expression networks[3]. However, the majority of pseudogenes, including the ethanolamine kinase 2 pseudogene, do not have proven functional protein products and are not used as drug targets, disease markers, or clinical therapeutic entities[1][2][3]. Summary: ENSG00000274468 refers to a pseudogene—not a receptor, enzyme, transporter, or established molecular target—and should not be confused with its functional counterpart, ethanolamine kinase 2. It does not encode a protein, does not participate as a direct therapeutic target, and has no known clinical or pharmacological significance[2][1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ethanolamine kinase 2 pseudogene.